Novo Nordisk chair foresees pressure on pharmaceutical industry

Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.

Photo: Novo Nordisk Pharmatech/PR

Novo Nordisk's Chair of the Board Helge Lund predicts that Danish tax payers will, to a large extent, be paying the bills for the coronavirus crisis in this country, but that the pharmaceutical industry will also be put under pressure, according to Danish media Finans.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs